Paket 10 vial6 stokHemat 25%PT-141 10 mg
Agonis melanokortin bremelanotide
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Hanya untuk keperluan penelitian. Senyawa ini dijual secara ketat untuk penelitian in-vitro dan keperluan laboratorium, dan tidak dimaksudkan untuk konsumsi manusia atau penggunaan terapeutik. Dengan membeli, Anda menegaskan bahwa Anda adalah peneliti yang memenuhi syarat dan menyetujui penyangkalan lengkap kami.
Tersisa 6 paket
Agonis reseptor melanokortin sintetis yang dikaji untuk efek pada jalur saraf yang terkait dengan respons seksual dalam aplikasi riset.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Riset menunjukkan agonisme primer pada MC4R dengan efek sistem saraf pusat pada penanda neurokimia pada subjek studi.
Diverifikasi HPLC terhadap spesifikasi kemurnian ≥99%. Diuji secara independen oleh laboratorium pihak ketiga terakreditasi.
PT-141 — pertanyaan yang sering diajukan
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Panduan terkait PT-141
Peneliti juga menelusuri
UnggulanPaket 10 vialHemat 17%HGH
Serbuk liofilisasi10 IU · 4 strengths
Hormon pertumbuhan manusia rekombinan
Dalam 2 stack
Paket 10 vialHemat 18%Tesamorelin
Serbuk liofilisasi10 mg · 3 strengths
Analog GHRH yang distabilkan
Dalam 1 stack
UnggulanPaket 10 vialHemat 22%CJC-1295 + Ipamorelin
Serbuk liofilisasi5 mg + 5 mg
Stack klasik GHRH + mimetik ghrelin
Dalam 2 stack